Publikace UTB
Repozitář publikační činnosti UTB

Cesta k datům: Stanoviska a doporučení pro poskytování zdravotních dat pro sekundární využití

Repozitář DSpace/Manakin

Zobrazit minimální záznam


dc.title Cesta k datům: Stanoviska a doporučení pro poskytování zdravotních dat pro sekundární využití cs
dc.title The way to data: opinions and recommendations for the provision of health data for secondary use en
dc.contributor.author Tichopád, Aleš
dc.contributor.author Augustynek, Martin
dc.contributor.author Beneš, Jiří
dc.contributor.author Dlouhý, Martin
dc.contributor.author Doležal, Tomáš
dc.contributor.author Horáková, Dana
dc.contributor.author Kršek, Michal
dc.contributor.author Lhotská, Lenka
dc.contributor.author Panzner, Petr
dc.contributor.author Penhaker, Marek
dc.contributor.author Petr, Miroslav
dc.contributor.author Piťha, Jan
dc.contributor.author Popesko, Boris
dc.contributor.author Rožánek, Martin
dc.contributor.author Táborský, Miloš
dc.contributor.author Vrablík, Michal
dc.relation.ispartof Časopis lékařů českých
dc.identifier.issn 0008-7335 Scopus Sources, Sherpa/RoMEO, JCR
dc.date.issued 2023
utb.relation.volume 162
utb.relation.issue 2-3
dc.citation.spage 61
dc.citation.epage 66
dc.type article
dc.language.iso cs
dc.publisher Czech Medical Association J.E. Purkyne
dc.relation.uri https://www.prolekare.cz/casopisy/casopis-lekaru-ceskych/2023-2-3-1/cesta-k-datum-stanoviska-a-doporuceni-pro-poskytovani-zdravotnich-dat-pro-sekundarni-vyuziti-134860
dc.subject anonymization en
dc.subject de-identification en
dc.subject EHDS en
dc.subject GDPR en
dc.subject health data en
dc.description.abstract Healthcare data held by state-run organisations is a valuable intangi-ble asset for society. Its use should be a priority for its administrators and the state. A completely paternalistic approach by administrators and the state is undesirable, however much it aims to protect the privacy rights of persons registered in databases. In line with European policies and the global trend, these measures should not outweigh the social benefit that arises from the analysis of these data if the technical possibilities exist to sufficiently protect the privacy rights of individuals. Czech society is having an intense discussion on the topic, but according to the authors, it is insufficiently based on facts and lacks clearly articulated opinions of the expert public. The aim of this article is to fill these gaps. Data anonymization techniques provide a solution to protect individu-als' privacy rights while preserving the scientific value of the data. The risk of identifying individuals in anonymised data sets is scalable and can be minimised depending on the type and content of the data and its use by the specific applicant. Finding the optimal form and scope of deidentified data requires competence and knowledge on the part of both the applicant and the administrator. It is in the interest of the applicant, the administrator, as well as the protected persons in the databases that both parties show willingness and have the ability and expertise to communicate during the application and its processing. © 2023, Czech Medical Association J.E. Purkyne. All rights reserved. en
utb.faculty Faculty of Management and Economics
dc.identifier.uri http://hdl.handle.net/10563/1012378
utb.identifier.scopus 2-s2.0-85165425330
utb.identifier.pubmed 37474288
utb.identifier.coden CLCEA
utb.source j-scopus
dc.date.accessioned 2025-04-07T07:16:59Z
dc.date.available 2025-04-07T07:16:59Z
utb.ou Department of Business Administration
utb.contributor.internalauthor Popesko, Boris
utb.scopus.affiliation Katedra biomedicínské techniky FBMI ČVUT v, Praze, Czech Republic; Katedra kybernetiky a biomedicínského inženýrství FEI VŠB – TU, Ostrava, Czech Republic; Ústav biofyziky a informatiky 1. LF UK v Praze, Czech Republic; Katedra ekonometrie FIS VŠE v Praze, Czech Republic; Institut pro zdravotní ekonomiku a technology assessment (iHETA), Praha, Czech Republic; Farmakologický ústav LF MU v Brně, Czech Republic; Neurologická klinika a Centrum klinických neurověd 1. LF UK a VFN v Praze, Czech Republic; 3. interní klinika – klinika endokrinologie a metabolismu 1. LF UK a VFN v Praze, Czech Republic; Katedra přírodovědných oborů FBMI ČVUT v Praze, Czech Republic; Ústav imunologie a alergologie LF UK a FN, Plzeň, Czech Republic; Katedra medicínského základu v kinantropologii FTVS UK v Praze, Czech Republic; Laboratoř pro výzkum aterosklerózy, IKEM, Praha, Czech Republic; Ústav podnikové ekonomiky FME UTB ve Zlíně, Czech Republic; I. interní klinika – kardiologická LF UP a FN, Olomouc, Czech Republic
Find Full text

Soubory tohoto záznamu

Soubory Velikost Formát Zobrazit

K tomuto záznamu nejsou připojeny žádné soubory.

Zobrazit minimální záznam